For instance, the study titled " PLK1 inhibition induces synthetic lethality in Fanconi anemia pathway-deficient acute myeloid leukemia "[24], published on March 20, 2025, emphasized the significance of the PLK1-FANCD2 interaction in cancer metabolism. This evidence concerns the gene FANCD2 and Fanconi anemia.